1 asset in D-Bifunctional Protein Deficiency

Therapeutic assets addressing D-Bifunctional Protein Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D D-Bifunctional Protein Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)